Clinical application value of Huanglian Jiedu Pills in improving syndrome of excess heat and fire toxin based on phase Ⅱ clinical trial study on plasma ATP, 4-HNE, and ACTH levels.
10.19540/j.cnki.cjcmm.20221008.502
- Author:
Ke-Ke LUO
1
;
Hai-Yu ZHAO
1
;
Nan SI
1
;
Bao-Lin BIAN
1
;
Wen XIA
2
;
Yun-Qin CHEN
2
;
Meng-Xiao WANG
1
;
Xiao-Lu WEI
1
;
Xing LI
2
;
Guang-Yuan QIN
2
;
Jian YANG
1
;
Yan-Yan ZHOU
1
;
Hong-Jie WANG
1
Author Information
1. Institute of Chinese Materia Medica, China Academy of Chinese Medical Sciences Beijing 100700, China.
2. Guizhou Bailing Group Pharmaceutical Co., Ltd. Anshun 561000, China.
- Publication Type:Journal Article
- Keywords:
4-hydroxynonenal;
Huanglian Jiedu Pills;
adenosine triphosphate;
adrenocorticotropic hormone;
plasma;
syndrome of excess heat and fire toxin
- MeSH:
Humans;
Adrenocorticotropic Hormone;
Hot Temperature;
Medicine, Chinese Traditional;
Adenosine Triphosphate
- From:
China Journal of Chinese Materia Medica
2023;48(4):1124-1131
- CountryChina
- Language:Chinese
-
Abstract:
A randomized, double-blind, placebo-controlled, multi-center phase Ⅱ clinical trial design was used in this study to recruit subjects who were in line with the syndrome of excess heat and fire toxin, and were diagnosed as recurrent oral ulcers, gingivitis, and acute pharyngitis. A total of 240 cases were included and randomly divided into a placebo group and a Huanglian Jiedu Pills group. The clinical efficacy of Huanglian Jiedu Pills in treating the syndrome of excess heat and fire toxin was evaluated by using the traditional Chinese medicine(TCM) syndrome scale. Enzyme-linked immunosorbent assay(ELISA) was used to determine and evaluate the levels of adenosine triphosphate(ATP), 4-hydroxynonenal(4-HNE), and adrenocorticotropic hormone(ACTH) in plasma of the two groups before and after administration and to predict their application value as clinical biomarkers. The results showed that the disappearance rate of main symptoms in the Huanglian Jiedu Pills group was 69.17%, and that in the placebo group was 50.83%. The comparison between the Huanglian Jiedu Pills group and the placebo group showed that 4-HNE before and after administration was statistically significant(P<0.05). The content of 4-HNE in the Huanglian Jiedu Pills group decreased significantly after administration(P<0.05), but that in the placebo group had no statistical significance and showed an upward trend. After administration, the content of ATP in both Huanglian Jiedu Pills group and placebo group decreased significantly(P<0.05), indicating that the energy metabolism disorder was significantly improved after administration of Huanglian Jiedu Pills and the body's self-healing ability also alleviated the increase in ATP level caused by the syndrome of excess heat and fire toxin to a certain extent. ACTH in both Huanglian Jiedu Pills group and placebo group decreased significantly after administration(P<0.05). It is concluded that Huanglian Jiedu Pills has a significant clinical effect, and can significantly improve the abnormal levels of ATP and 4-HNE in plasma caused by the syndrome of excess heat and fire toxin, which are speculated to be the effective clinical biomarkers for Huanglian Jiedu Pills to treat the syndrome of excess heat and fire toxin.
